High-performance CRISPR-Cas12a genome editing for combinatorial genetic screening
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-performance CRISPR-Cas12a genome editing for combinatorial genetic screening
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-14
DOI
10.1038/s41467-020-17209-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic interaction mapping and exon-resolution functional genomics with a hybrid Cas9–Cas12a platform
- (2020) Thomas Gonatopoulos-Pournatzis et al. NATURE BIOTECHNOLOGY
- Engineered CRISPR–Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing
- (2019) Benjamin P. Kleinstiver et al. NATURE BIOTECHNOLOGY
- In vivo profiling of metastatic double knockouts through CRISPR–Cpf1 screens
- (2019) Ryan D. Chow et al. NATURE METHODS
- HBO1 is required for the maintenance of leukaemia stem cells
- (2019) Laura MacPherson et al. NATURE
- Mapping the Genetic Landscape of Human Cells
- (2018) Max A. Horlbeck et al. CELL
- On the design of CRISPR-based single-cell molecular screens
- (2018) Andrew J Hill et al. NATURE METHODS
- Uncoupling of sgRNAs from their associated barcodes during PCR amplification of combinatorial CRISPR screens
- (2018) Mudra Hegde et al. PLoS One
- Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth
- (2018) Jonathan B. Baell et al. NATURE
- A case of mistaken identity
- (2018) Ruth E Hanna et al. NATURE BIOTECHNOLOGY
- Orthologous CRISPR–Cas9 enzymes for combinatorial genetic screens
- (2017) Fadi J Najm et al. NATURE BIOTECHNOLOGY
- Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions
- (2017) Kyuho Han et al. NATURE BIOTECHNOLOGY
- Combinatorial CRISPR–Cas9 screens for de novo mapping of genetic interactions
- (2017) John Paul Shen et al. NATURE METHODS
- Genetic interaction mapping in mammalian cells using CRISPR interference
- (2017) Dan Du et al. NATURE METHODS
- Flexible CRISPR library construction using parallel oligonucleotide retrieval
- (2017) Abigail Read et al. NUCLEIC ACIDS RESEARCH
- A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response
- (2016) Britt Adamson et al. CELL
- Multiplex gene editing by CRISPR–Cpf1 using a single crRNA array
- (2016) Bernd Zetsche et al. NATURE BIOTECHNOLOGY
- Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition
- (2016) Anja F Hohmann et al. Nature Chemical Biology
- Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM
- (2016) Alan S. L. Wong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
- (2015) Bernd Zetsche et al. CELL
- Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains
- (2015) Junwei Shi et al. NATURE BIOTECHNOLOGY
- High-throughput functional genomics using CRISPR–Cas9
- (2015) Ophir Shalem et al. NATURE REVIEWS GENETICS
- Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation
- (2013) J. Shi et al. GENES & DEVELOPMENT
- DNA targeting specificity of RNA-guided Cas9 nucleases
- (2013) Patrick D Hsu et al. NATURE BIOTECHNOLOGY
- The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells
- (2012) William J. Harris et al. CANCER CELL
- The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;NrasG12D acute myeloid leukemia
- (2012) J Shi et al. ONCOGENE
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
- (2011) Kathrin M. Bernt et al. CANCER CELL
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
- (2011) Mark A. Dawson et al. NATURE
- Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi
- (2010) Johannes Zuber et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search